Stephen Chan

18.9k citations
178 papers · 11.4k · 3 hit papers · h-index 47

Impact in

  • Oncology top 0.1%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Treatment and Pharmacology 40
    • HER2/EGFR in Cancer Research 22
    • Cancer-related Molecular Pathways 10
    • DNA Repair Mechanisms 23

Stephen Chan

171 papers receiving 11.0k citations

Stephen Chan's Hit Papers

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer 2011 · 795 citations
7950+7+14Years since publication50010001.5k2.0k2.5k

Peers

Stephen Chan
Comparison fields: 5 of 130
  • Oncology 6.1k
  • Cancer Research 2.1k
  • Pulmonary and Respiratory Medicine 2.0k
  • Radiology, Nuclear Medicine and Imaging 1.3k
  • Molecular Biology 3.4k
Replace Herbert A. Fritsche with:
Herbert A. Fritsche United States
P. Fumoleau France
Robert W. Ross United States
Philippe L. Bédard Canada
Jean-­Marc Ferrero France
Kimberly Blackwell United States
Fabio Puglisi Italy
Virginia Paton United States
Angelo Di Leo Italy
Joan Albanell Spain
Stephen Chan relative to Herbert A. Fritsche United States Herbert A. Fritsche's profile →
Citations per field
00.5×1.5×2.0×
Herbert A. Fritsche · 1×
Citations per year

Countries citing papers authored by Stephen Chan

Since Specialization
Citations

This map shows the geographic impact of Stephen Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Chan more than expected).

Fields of papers citing papers by Stephen Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Chan. The network helps show where Stephen Chan may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen Chan Line = papers co-authored together Stephen Chan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Hit paper breakdown →
20062638
2
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
Hit paper breakdown →
20051215
3
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
Hit paper breakdown →
2011795
4 2005408
5 2003304
6 2008277
7 2004259
8 2013216
9 2008170
10 2003160
11 2004139
12 2004135
13 2004124
14 2004123
15 2010122
16 2003120
17 2000120
18 2010113
19 2011105
20 2006100

About Stephen Chan

Stephen Chan is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 178 papers that have together received 11.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (40 papers), Breast Cancer Treatment Studies (24 papers), DNA Repair Mechanisms (23 papers), HER2/EGFR in Cancer Research (22 papers), Ovarian cancer diagnosis and treatment (13 papers), Estrogen and related hormone effects (11 papers), Advanced Breast Cancer Therapies (11 papers) and Cancer-related Molecular Pathways (10 papers). The work is most often cited by research in Oncology (6.1k citations), Cancer Research (2.1k citations), Pulmonary and Respiratory Medicine (2.0k citations), Radiology, Nuclear Medicine and Imaging (1.3k citations) and Molecular Biology (3.4k citations). Stephen Chan has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Tadeusz Pieńkowski, Arlene Chan, John Crown, Mark S. Berger, Mario Campone, David Cameron, Dimosthenis Skarlos, Bella Kaufman, Neville Davidson and Cristina Oliva. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, Breast Cancer Research and Treatment and Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact